Enter your login e-mail to the account
Search
Search parameters
Search results
- ATRIAL FIBRILLATION IN GENERAL PRACTITIONER‘S PRACTICE AND VALUE OF RAAS INHIBITORS IN PREVENTION AND TREATMENT OF THIS ARRHYTHMIA
MUDr. Peter Jonáš, MUDr. Anton Farkaš
(12/2007, clearly ) - Pharmacological therapy of the heart failure
doc. MUDr. Peter Mitro, PhD.
(1/2009, Review articles ) - New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles ) - Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Overview of results in selected pharmacoeconomic studies with valsartan
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(11/2009, Pharmacoeconomics ) - Current perspective on treating erectile dysfunction in the general practitioner's surgery
MUDr. Pavel Turčan
(1/2016, Interdisciplinary consilium ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Pohled na otázky kardiovaskulárního rizika moderních nesteroidních antirevmatik
MUDr. David Suchý
(4/2004, Spectrum ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Overview of results in selected in pharmacoeconomic study of ACEi ramipril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(2/2009, Pharmacoeconomics ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN PATIENTS WITH CORONARY HEART DISEASE
PharmDr. Lívia Magulová, PhD., h. doc. MUDr. Jana Sirotiaková, PhD., MUDr. Peter Minárik
(4-5/2008, clearly ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - PSORIASIS – NEWS IN PATHOGENESIS AND THERAPY
MUDr. Zoltán Szép
(3/2005, Topic ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - NON-OPIOID ANALGETICS IN THE TREATMENT OF CHRONIC PAIN
MUDr. Igor Martuliak, PhD.
(6/2005, Topic ) - COXIBS IN RHEUMATOLOGY
doc. MUDr. Jozef Lukáč, CSc., prof. MUDr. Jozef Rovenský, DrSc., MUDr. Oľga Lukáčová, PhD.
(2/2005, Topic ) - POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(1/2007, Topic ) - Fixed-dose combinations of calcium channel blockers and angiotensin-converting enzyme inhibitors in hypertension
MUDr. Slavomír Šuch
(3/2010, Drugs & drug classes ) - COVID-19, ibuprofén, inhibítory angiotenzín-konvertujúceho enzýmu, sartany
MUDr. Mgr. Jaroslav Hrenák, PhD., MUDr. Kristína Repová, PhD.
(2/2020, Information & comments ) - MYASTHENIA GRAVIS IN GENERAL PRACTITIONER´S OUT-PATIENTS´S DEPARTMENT
doc. MUDr. Peter Špalek, CSc.
(6/2008, Consilium ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - TREATMENT OF PATIENT WITH CONGESTIVE HEART FAILURE
prof. MUDr. Ján Murín, CSc.
(9/2006, Main topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - ARE THE PROBLEMS OF THE TREATMENT OF PEPTIC ULCER DISEASE 23 YEARS AFTER DISCOVERING HELICOBACTER PYLORI SOLVED?
MUDr. Rudolf Hrčka, CSc.
(10/2006, Main topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - Medications, natural substances, and dietary supplements in treating sexual dysfunctions: a sexologist’s perspective
MUDr. Ondřej Trojan
(1/2017, Electronic attachment ) - Depressive disorders in general practitioners practice – part I.
MUDr. Peter Marko
(10/2009, General Medicine ) - Triple therapy with protease inhibitors – new standard of care in chronic hepatitis C treatment
doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Peter Jarčuška, PhD.
(6/2011, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - Benign prostatic hyperplasia, diagnostics and contemporary opportunities of miniinvasive treatment
MUDr. Jiří Klečka, Ph.D., MUDr. Petr Běhounek, doc. MUDr. Milan Hora, Ph.D., MUDr. Viktor Eret
(1/2011, Interdisciplinary consilium ) - OPTIMAL (TARGET) DOSING OF ACE INHIBITORS
doc. MUDr. Jana Sirotiaková, PhD., PhD., Peter Minárik
(12/2008, clearly )
- Recommendations for the treatment of unipolar depressive disorder
MUDr. Ľubica Forgáčová, PhD.
(4/2010, Recommendations for practice ) - Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology ) - Tobacco smoking and depression
MUDr. Michal Turček, PhD.
(2/2013, Review articles ) - Interactions of tobacco smoke with psychotropic medications
MUDr. Michal Turček, PhD.
(4/2011, Review articles ) - Current trends in the cognitive pharmacotherapy of Alzheimer´s disease
MUDr. Roman Jirák, CSc.
(2/2002, Review articles ) - GENDER DIFFERENCES IN THE STRESS RESPONSE AND IN THE ACTION OF ANTIDEPRESSANT DRUGS
doc. MUDr. Daniela Ježová, DrSc.
(3/2004, Review articles ) - Demention with Lewy’s Bodies, Diagnosis, Clinical Meaning, Treatment
MUDr. Jiří Konrád
(1/2004, Review articles ) - PHARMACOTHERAPY OF DEMENTIA
doc. MUDr. Vladimír Pidrman, Ph.D.
(5/2007, Review articles ) - Nové trendy v léčbě obsedantně kompulzivní poruchy
MUDr. Pavla Stopková, Ph.D.
(2/2018, Review articles ) - Friedrich Heinrich Lewy, his corpuscles and their illnesses
Prof. MUDr. Petr Kaňovský, CSc., MUDr. Kateřina Menšíková, Ph.D., prof. MUDr. Ing. Petr Hluštík, Ph.D.
(1/2017, Review articles ) - Treatment discontinuation in anxiety and depressive disorders
MUDr. Jiřina Kosová
(2/2004, Review articles ) - Dysthymia and its therapy
MUDr. Ján Praško, CSc. , MUDr. Erik Herman, doc. MUDr. Jiří Hovorka, CSc.
(6/2002, Review articles ) - Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles ) - Sexual dysfunctions and longterm antidepressants intaken
MUDr. Luboš Janů, Ph.D.
(1/2001, Review articles ) - Long-term use of cognitive drugs in Alzheimer disease
MUDr. Vanda Franková
(4/2004, Review articles ) - Circadian rhythms and depression
MUDr. Michal Maršálek, CSc.
(2/2012, Review articles ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(4/2016, Review articles ) - New perspectives in the treatment of bipolar affective disorder
MUDr. Iveta Fiziková, MUDr. Milena Drímalová, CSc.
(1/2013, Review articles ) - Combined therapy by Alzheimer´s disease
MUDr. Elena Žigová
(1/2013, Original articles & case reports ) - THE USE OF DUAL ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSIVE DISORDER
MUDr. Luboš Janů, Ph.D. , MUDr. Sylva Racková
(6/2008, Review articles ) - Repetitive transcranial magnetic stimulation in the treatment of depression
MUDr. Bc. Libor Ustohal
(5–6/2010, Review articles ) - SSRI IN THE SPECTRUM OF ANXIETY DISORDERS
doc. MUDr. Vladimír Pidrman, Ph.D.
(1/2003, Review articles ) - Interdisciplinary approach in dementia treatment by cholinesterase inhibitors
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, doc. MUDr. Jiří Horáček, CSc.
(3/2003, Review articles ) - Antidepressant – indued sexual dysfunction
MUDr. Michal Maršálek, CSc.
(3/2003, Review articles ) - THERAPEUTICAL APPROACHES IN BEHAVIORAL DISORDERS IN DEMENTIA
MUDr. Vanda Franková
(6/2007, Review articles ) - CURRENT TRENDS IN THE BIOLOGICAL TREATMENT OF ALZHEIMER DISEASE
MUDr. Roman Jirák, CSc.
(1/2006, Review articles ) - THE TREATMENT OF PSYCHOTIC DEPRESSION – ACUTE AND CONTINUATION DRUG TREATMENT
MUDr. Martin Bareš, MUDr. Miloslav Kopeček
(1/2006, Review articles ) - Venlafaxin s prodlouženým uvolňováním v ambulantní praxi
MUDr. Luboš Janů, Ph.D.
(1/2006, Outpatient psychiatry ) - TREATMENT OF DEPRESSION WITH ANXIETY AND INSOMNIA
MUDr. Jiřina Kosová
(1/2007, Review articles ) - BEHAVIORAL DISTURBANCES IN DEMENTIA
MUDr. Martin Brunovský, Ph.D.
(2/2006, Review articles ) - PHARMACOTHERAPEUTIC OPTIONS IN DEPRESSION
prof. MUDr. Eva Češková, CSc.
(5/2005, Review articles ) - DEPRESSION, METABOLIC SYNDROME AND DIABETES MELLITUS
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(2/2006, Review articles ) - NEW TREATMENT POSSIBILITIES FOR BIPOLAR DEPRESSION
prof. MUDr. Eva Češková, CSc.
(3/2006, Review articles ) - Psychosomatic and psychosocial issues of cardiovascular diseases
prof. MUDr. Jaroslav Šimon, DrSc.
(1/2004, Review articles ) - ATYPICAL ANTIPSYCHOTICS IN TREATMENT RESISTANT DEPRESSION
MUDr. Dagmar Seifertová, CSc., MUDr. Martin Bareš, Ph.D., MUDr. Milan Kopeček
(3/2006, Review articles ) - DEPRESSION, CORONARY ARTERY DISEASE, AND MYOCARDIAL INFARCTION
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(4/2006, Review articles ) - A surprising effect of memantine on the progression of Alzheimer‘s disease
MUDr. Jan Kolouch, CSc., MUDr. František Koukolík, DrSc., MUDr. Barbora Balíková
(4/2010, Original articles & case reports )
- Therapeutic advances in hereditary muscular disorders
MUDr. Stanislav Voháňka, CSc., MBA
(3/2011, Review articles ) - Autoantibody-mediated disorders of the neuromuscular junction
doc. MUDr. Peter Špalek, PhD.
(2/2010, Main topic ) - Practical experience with the clinical diagnosis of myasthenia gravis
MUDr. Jiří Piťha
(2/2010, Main topic ) - Myasthenia gravis with anti-MuSK antibodies
Doc. MUDr. Edvard Ehler, CSc., MUDr. Jiří Piťha
(5/2017, Main topic ) - RNA interferencia – nový nástroj génovej terapie
Bc. Branislav Kusenda, RNDr. Šárka Pospíšilová, Ph.D.
(2/2006, Main topic ) - Myasthenia gravis and woman: pregnancy, delivery, postpartum period and transient neonatal myasthenia
doc. MUDr. Peter Špalek, PhD.
(6/2014, Main topic ) - Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - MuSK antibody positive myasthenia gravis – our experience
doc. MUDr. Peter Špalek, PhD., MUDr. Ivan Martinka, PhD., MUDr. Štefan Kečkeš
(2/2021, Main topic ) - Tumors of the central nervous system in children
MUDr. Zdeněk Pavelka, MUDr. Karel Zitterbart
(1/2011, From the boundary of neurology ) - Clinical and genetic heterogenity of dopa-responsive dystonia
MUDr. Ján Necpál
(3/2015, Video case reports ) - NBIA – neurodegeneration with brain iron accumulation
prof. MUDr. Petr Kaňovský, CSc., MUDr. Lenka Hvizdošová, MUDr. Michaela Kaiserová, Ph.D., doc. MUDr. Marek Baláž, Ph.D.
(5/2016, Video case reports ) - POKROKY V GENETIKE NEUROVÝVOJOVÝCH PORÚCH
prof. MUDr. Ľubomír Lisý, DrSc.
(4/2007, Review articles ) - Účinnost a snášenlivost galantaminu v léčbě Alzheimerovy nemoci
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, , RNDr. Ing. Karel Chroust, Ph.D.
(5/2006, Review articles ) - Idiopathic inflammatory myopathies – new advances
prof. MUDr. Jiří Vencovský, DrSc.
(6/2020, From the boundary of neurology ) - Cardiac function in hypertensive patients with metabolic syndrome and microalbuminuria
MUDr. Jiří Piťha
(3/2016, Review articles ) - Pyridoxine-dependent epilepsy – new trends in diagnosis and treatment
MUDr. Lia Elstnerová, doc. RNDr. Lenka Fajkusová, CSc., MUDr. Štefania Rusnáková, doc. MUDr. Hana Ošlejšková, Ph.D., Mgr. Eva Jansová, Ph.D., Mgr. Pavla Šultesová, doc. MUDr. Dalibor Valík, Ph.D.
(5/2010, Review articles ) - Treatment of Parkinson’s disease
prof. MUDr. Ivan Rektor, CSc.
(6/2009, Main topic ) - INHIBITORY CHOLINESTERÁZ V LÉČBĚ ALZHEIMEROVY NEMOCI
MUDr. Martin Brunovský, Ph.D.
(2/2007, Review articles ) - Parkinsonian syndrome and extrapyramidal symptoms in neurodegenerative diseases associated with disorders of iron metabolism
MUDr. Petra Bártová, Ph.D.
(3/2012, Main topic ) - Genetic causes of parkinsonism with focus on spinocerebellar ataxias
MUDr. Matej Škorvánek, doc. MUDr. Peter Valkovič, PhD.
(3/2012, Main topic ) - Neurological complications of cancer immunotherapy
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN
(5/2023, Main topic ) - Pompe disease – case report of the juvenile form
MUDr. Katarína Okáľová, PhD., Mgr. Slavomíra Mattošová, doc. MUDr. Ján Chandoga CSc., MUDr. Viera Holecová
(1/2015, Case reports ) - Deprese u neurologických onemocnění: výskyt a její léčba
MUDr. Sylva Racková
(3/2018, From the boundary of neurology ) - Friedrich Heinrich Lewy, his corpuscles and their illnesses
prof. MUDr. Petr Kaňovský, CSc., prof. MUDr. Ing. Petr Hluštík, Ph.D., MUDr. Kateřina Menšíková, Ph.D.
(4/2016, From the history of neurology ) - Eye of tiger sign in patient with extrapyramidal syndrome – unique case report
MUDr. Martin Daniš, MUDr. Juraj Cisár, MUDr. Georgi Krastev, PhD.
(4/2020, Video case reports ) - Tratable childhood-onset movement disorders: pragmatic approach and case-report of a patient with dopa-responsive dystonia
Doc. MUDr. Matej Škorvánek, PhD.
(6/2019, Video case reports ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Alzheimer’s disease and mild cognitive impairment: diagnosis and treatment
MUDr. David Doležil, Ph.D. , RNDr. Daniela Řípová, CSc., doc. MUDr. Aleš Bartoš, Ph.D., MUDr. Linda Čechová
(3/2011, Review articles ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic ) - Rhabdomyolysis
doc. MUDr. Peter Špalek, PhD.
(4/2012, Main topic ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Ovomucoid and ovoinhibitors in the treatment of allergic diseases
MUDr. Martin Matejka, PhD., MUDr. Jana Malinová, MVDr. Ladislav Čižmárik
(1/2017, Review articles ) - CURRENT VIEW ON THE PATHOGENESIS AND MANAGEMENT OF ATOPIC DERMATITIS
MUDr. Dušan Buchvald Ph.D.
(2/2005, Review articles ) - INFLUENZA IN CHILDREN
MUDr. Zuzana Blechová
(6/2007, Review articles ) - Topical immunomodulators in the treatment of atopic dermatitis
prof. MUDr. Jagienka Jautová, PhD., MBA, MUDr. Janette Baloghová, PhD.
(3/2009, Drugs & drug classes ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(5/2015, Review articles ) - Achondroplasia – orphan disease, orphan treatment
MUDr. Ľubica Tichá, PhD., MPH
(5/2022, Encyclopedia of rare diseases ) - Recurrent fever in children
MUDr. Petra Król, prof. MUDr. Pavla Doležalová, CSc.
(5/2013, Review articles )
- The actual pharmacotherapy benign hyperplasia according to EAU Guidelines
MUDr. Aleš Horák
(3/2021, Review articles ) - Treatment of metastatic clear-cell renal cell carcinoma – cabozantinib – experience and inclusion in treatment algorithm
MUDr. Jana Katolická, Ph.D., MUDr. Sabina Svobodová, doc. MUDr. Jiří Vaníček, Ph.D., Mgr. Pavlína Prosecká, MUDr. Petr Filipenský, Ph.D.
(4/2018, Review articles ) - Renal carcinoma and immunotherapy
MUDr. Alexandr Poprach, Ph.D., MUDr. Radek Lakomy, Ph.D.
(2/2017, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - Imunoterapie u nádorů ledvin
MUDr. Andrea Ondrušková, doc. MUDr. Hana Študentová, Ph.D.
(3/2023, Review articles ) - Treatment of urothelial carcinoma bladder cancer
MUDr. Jana Katolická, Ph.D., MUDr. Lucia Tomková
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology ) - ERECTILE DYSFUNCTION – NEW PREFERENCES IN TREATMENT?
MUDr. Libor Zámečník, FEBU
(1/2008, Review articles ) - Drug interactions in urology – what to watch out for
PharmDr. Josef Suchopár, MUDr. Michal Prokeš, Štěpán Suchopár
(2/2020, Drug interaction ) - Drug interactions of medications used in the therapy of erectile dysfunction with dietary supplements
PharmDr. Josef Suchopár, Mgr. Štěpán Suchopár, MUDr. Michal Prokeš
(2/2023, Drug interaction )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Current treatment options for BRAF mutant metastatic colorectal cancer
MUDr. Radovan Barila, PhD., MUDr. Igor Andrašina, CSc.
(1/2022, Main topic ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Systemic treatment of neuroendocrine tumours
MUDr. Katarína Štefániková
(5/2021, Main topic ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Hereditary form of malignant melanoma associated with mutations in CDKN2A gene
doc. MUDr. Juraj Kaušitz, CSc., RNDr. Zdena Bartošová, CSc., RNDr. Miriam Milly, PhD., RNDr. Michal Konečný, PhD., RNDr. Katarína Závodná, PhD., RNDr. Eva Weismanová, PhD.
(2/2010, Review articles ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Recommendations for the management of patients with chronic myelocytic leukemia in the Slovak Republic
Kolektív autorov
(S1/2021, Supplement ) - Gastrointestinal stromal tumors (GISTs)
MUDr. Iveta Andrezálová Vochyanová
(3/2011, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Diagnosis of chronic myeloid leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Lucia Copáková, MUDr. Eva Mikušková, Mgr. Michaela Leitnerová
(2/2012, Topic of the year ) - Marginal zone lymphoma
MUDr. Juraj Ďuraš , MUDr. Michal Kaščák, prof. MUDr. Roman Hájek, CSc.
(5/2017, Spectrum ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - New recommendations for adjuvant and first-line treatment of metastatic clear cell renal carcinoma
MUDr. Milan Krošlák
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - BIOPTIC DIAGNOSIS OF GASTROINTESTINAL STROMAL TUMORS
prof. MUDr. Lukáš Plank, CSc.
(2/2007, Review articles ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Systemic therapy of metastatic melanoma
MUDr. Tomáš Šálek
(6/2021, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - News in the treatment of non-small cell lung cancer in the first half of 2023 in the world and new therapies in Slovakia
MUDr. Dominik Šafčák, PhD., MPH
(S2/2023, Review articles ) - HIF inhibitors and glutaminase inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Zuzana Tomčová
(3/2024, Main topic ) - Gastrointesintal stromal tumors – new possibilities in the strategy of treatment
MUDr. Matej Hrnčár, MUDr. Eva Pritzová
(1/2019, Main topic ) - Advances in molecular monitoring and the importance of screening BCR/ABL1 mutation for Ph-positive chronic myelocytic leukemia
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(1/2019, Review articles ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - New trends in the treatment of Ph+ acute lymphoblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., MUDr. Iveta Simančíková, MUDr. Ladislav Sopko, PhD., MUDr. Katarína Slezáková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2017, Original articles & case reports ) - CHRONIC LYMPHOCYTIC LEUKEMIA – BIOLOGY, PROGNOSIS AND CLINICAL PICTURES (PART 1)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(5/2008, Review articles ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Polycytémia vera – súčasný pohľad na diagnostiku a liečbu
MUDr. Antónia Hatalová, PhD., MUDr. Jana Malinová, doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, CSc.
(3/2018, Spectrum ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Advances in the treatment of T-cell lymphomas
MUDr. Lucia Petríková, PhD., MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(6/2022, Main topic ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - CHRONIC MYELOID LEUKEMIA – NEW TRENDS IN THE TREATMENT
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(5/2008, Review articles ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - CHEMOPREVENTION OF BREAST CANCER
prof. MUDr. Ľudovít M. Jurga, DrSc., prof. MUDr. Myrón Malý, CSc.
(5/2007, Review articles ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - TREATMENT OF CHRONIC MYELOID LEUKEMIA IN KHAT BRATISLAVA DURING 2002 – 2007
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, MUDr. Eva Demečková
(6/2008, Original articles ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Decision-making algorithm in the therapy of patients with advanced malignant melanoma
MUDr. Silvia Jurišová, PhD.
(1/2024, Review articles ) - The role of osimertinib in the treatment of lung cancer
MUDr. Anna Kollárová
(1/2024, Drugs & drug classes ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - Treatment of patients with FLT3 positive acute myeloblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2019, Review articles ) - Updated ESMO recommendations for the treatment of newly diagnosed ovarian epithelial carcinoma
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2022, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Ibrutinib in treatment of Waldenström´s makroglobulinemia – case report
MUDr. Aneta Matysová
(4/2017, Original articles & case reports ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - The effect of ruxolitinib on quality of life – a case report
MUDr. Daniela Kubincová
(S2/2020, Case reports ) - HODGKIN`S LYMPHOMAS – CURRENT DIAGNOSTICS AND TREATMENT
MUDr. Jan Hudeček, CSc.
(2/2006, Review articles ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - Molecular classification of liposarcomas
RNDr. Katarína Hlinková
(6/2011, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Tacrolimus in treatment of atopic dermatitis
MUDr. Janette Baloghová, PhD., prof. MUDr. Jagienka Jautová, PhD.
(3/2011, Drugs & drug classes ) - Subacute cutaneous lupus erythematodes in a patient with SHARP syndrome – case report
MUDr. Barbora Gulánová, MUDr. Martina Part, PhD., prof. MUDr. Mária Šimaljaková, PhD, MHA
(2/2017, Original articles & case reports ) - Psoriasis and options of balneotherapy
MUDr. Ján Lidaj, MUDr. Alena Masarovičová
(1/2012, Review articles ) - BIOLOGICA TREATMENT OF PSORIATIC ARTHRITIS
MUDr. Liliana Šedová, MUDr. Jiří Štolfa
(2/2007, Interdisciplinary overviews ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(1/2015, Review articles ) - Advers skin effect of target therapy in oncology
MUDr. Katarína Poláková, PhD.
(4/2018, Review articles ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles ) - Upadacitinib in the treatment of atopic dermatitis
MUDr. Karolína Vorčáková, PhD.
(2/2023, Drugs and drug groups )
- POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(3-4/2007, clearly ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly ) - EFFECTIVITY AND SAFETY OF COXIBS
doc. MUDr. Jozef Lukáč, CSc., MUDr. Oľga Lukáčová, CSc.
(3-4/2007, clearly ) - OBSESSIVE-COMPULSIVE DISORDER
MUDr. Branislav Moťovský
(3/2008, Review articles ) - DIAGNOSTICS AND TREATMENT OF DEPRESSION IN DIABETES MELLITUS
MUDr. Ľubica Forgáčová, PhD.
(3/2008, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly ) - COMBINATION THERAPY FOR HYPERTENSION
Doc. MUDr. Milan Grundmann, CSc., MUDr. Ivana Kacířová
(2/2007, clearly ) - ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Current opinions on the treatment of glaucoma
prof. MUDr. Gabriela Nosáľová, DrSc., doc. RNDr. Soňa Fraňová, PhD., MUDr. Peter Žiak, PhD., MUDr. Milena Čipkalová, doc. MUDr. Juraj Mokrý, PhD.
(4/2012, Current pharmacotherapy ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(3/2016, Current pharmacotherapy ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Current possibilities of benign prostatic hyperplasia therapy part I.
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2012, Current pharmacotherapy ) - Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Huperzine A and other natural substances in treating Alzheimer's disease
PharmDr. Jan Martin, Mgr. Zuzana Kršková, doc. RNDr. Jaroslav Dušek, CSc.
(2/2011, Phytotherapy ) - Current trends in treatment of atopic dermatitis – a minimum for pharmacists
MUDr. Petra Brodská, Ph.D.
(3/2023, Current pharmacotherapy )
- Microcirculation in intestinal mucosa and its conextion to IBD
MUDr. Petronela Bušíková, PhD., doc. MUDr. Ján Porubský, CSc.
(3-4/2012, Review articles ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles ) - Hemophilia A and risk of inhibitor development – what changed the SIPPET study?
Prof. MUDr. Ján Staško, PhD., MUDr. Juraj Sokol, PhD., MUDr. Lucia Stančiaková, PhD., MUDr. Tomáš Šimurda, MUDr. Pavol Hollý, PhD, prof. MUDr. Peter Kubisz, DrSc.
(3-4/2017, Main topic ) - Acquired hemophilia A
Doc. MUDr. Mária Hulíková, PhD.
(3-4/2017, Main topic ) - Thrombocytosis and thrombosis in myeloproliferative neoplasms
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Main topic )
- Gastrointestinal stromal tumor (GIST) of duodenum manifested as gastrointestinal bleeding – case report
MUDr. Ivan Kováč, PhD., MUDr. Marián Kudláč, doc. MUDr. Jozef Belák, PhD., MUDr. Peter Švajdler, MUDr. Martin Novotný, MPH
(1/2017, Case report ) - The role and importance of measuring fibrinolytic agents uPA and PAI-1 in oncosurgical patients
MUDr. Soňa Huľová, MUDr. Edward Huľo, MUDr. Lucia Rišková, doc. MUDr. Jana Kaťuchová, PhD.
(2-3/2017, Review articles ) - Stomach gists in our repertoire of patients
MUDr. Vladimír Dudáš, doc. MUDr. Augustín Prochotský, CSc., MUDr. Martin Nemček, MUDr. Peter Levčík
(3-4/2018, Case report ) - Multivisceral resection as a treatment option for a large gastrointestinal stromal tumor - a case report
MUDr. Monika Miklóšová, doc. MUDr. Jozef Belák, PhD., MUDr. Marián Kudláč, MUDr. Ivan Kováč, PhD.
(1-2/2020, Case report )